Establishment of a Tumor Bank for Tissue Samples

Studien-Informationen

Ein-/Ausschlusskriterien

Studien-Rationale

Studien-Arme

• Malignant tumors
  Patients who have one of the Neoplasms stated above under "conditions".
• Benign controls
  Patients with a benign tumor or an inflammatory disease - to be matched by age.
• Healthy controls
  People/patients who have no known disease at time of sampling or are admitted to the hospital for minor interventions and have no inflammatory disease.

Geprüfte Regime

• Tumor tissue collection:
  Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon. Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis. Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.
• Sampling of ascites and pleural effusion:
  Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.
• Collecting urine samples:
  Patient is asked to give a urine sample. Urine is collected in urine beaker.
• Collecting saliva sample:
  Saliva sample is collected by spatula from the mouth cavity of the patient.
• Collecting sputum:
  Patient is asked to produce sputum into a 50ml lab tube.
• Collecting stool samples:
  Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.
• Lavage/Irrigation:
  Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.

Quelle: ClinicalTrials.gov